VIENNA&8211;BUSINESS WIRE&8211;Celgene International Srl a whollyowned subsidiary ofÂCelgene Corporation NASDAQ CELGÂtoday announced that data from a randomized doubleblind multicenter exploratory phase 1b study evaluating the effects of investigat...
↧